Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Date Article Titlesort descending Journal

Kirill Zhudenkov, Sergey Gavrilov, Alina Sofronova, Oleg Stepanov, Nataliya Kudryashova, Gabriel Helmlinger, Kirill Peskov

 January 2022 A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics ASCPT

Wei-xiang Qi, Lu Cao, Cheng Xu, Shengguang Zhao, Jiayi Chen

 February 2020 Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials The Breast

Yifei Sun, Xuming He, Jianhua Hu

 December 2022 An omnibus test for detection of subgroup treatment effects via data partitioning Annals of Applied Statistics

Anne A. Eaton, Emily C. Zabor

 December 2021 Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules Statistics in Medicine

Yu, Peter MD, ET AL

 February 2022 Artificial Intelligence Comes of Age in the Fight Against Cancer Oncology Times

Omar Abdel-Rahman

 June 2019 Asian Americans have better outcomes of non-metastatic gastric cancer compared to other United States racial groups: A secondary analysis from a randomized study World Journal of Gastrointestinal Oncology

Jean Coquet, PhD; Nicolas Bievre, MS; Vincent Billaut, MS; Martin Seneviratne, MD; Christopher J. Magnani, MPhil; Selen Bozkurt, PhD; James D. Brooks, MD; Tina Hernandez-Boussard, PhD

 February 2021 Assessment of a Clinical Trial–Derived Survival Model in Patients With Metastatic Castration-Resistant Prostate Cancer JAMA Network Open

Bethany Pitcher, Leila Khoja, Robert J. Hamilton, Kald Abdallah, Melania Pintilie, Anthony M. Joshua

 February 2017 Assessment of a Prognostic Model, PSA Metrics and Toxicities in Metastatic Castrate Resistant Prostate Cancer using Data from Project Data Sphere. PLOS ONE

Wei-Xiang Qi, Yi Xiang, Shengguang Zhao & Jiayi Chen 

 April 2021 Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab Cancer Immunology, Immunotherapy

Guru Sonpavdea, Gregory R.Pond, Arnoud J.Templeton, Abderrahim Fandi, Bertrand Tombale, Mark Rosenthal, Andrew J.Armstrong, Daniel P.Petrylakh

 June 2016 Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel European Urology

Garrett S Bullock,Patrick Ward,Scott Peters, Amelia Joanna Hanford Arundale , Andrew Murray,Franco M Impellizzeri, Stefan Kluzek

 June 2022 Call for open science in sports medicine British Journal of Sports Medicine

Zahra Azizi, Chaoyi Zheng, Lucy Mosquera, Louise Pilote, Khaled El Emam, GOING-FWD Collaborators Correspondence to Dr Khaled El Emam; kelemam@ehealthinformation.ca

 March 2021 Can synthetic data be a proxy for real clinical trial data? A validation study BMJ Open

Deborah Plana, Geoffrey Fell, Brian M. Alexander, Adam C. Palmer & Peter K. Sorger 

 February 2022 Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects Nature Communications

Jeffrey West, Yongqian Ma, Paul K. Newton

 October 2018 Capitalizing on Competition: An Evolutionary Model of Competitive Release in Metastatic Castration Resistant Prostate Cancer Treatment Journal of Theoretical Biology

Pages